A Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Tacrolimus and Corticosteroids in Combination With or Without Mycophenolate Mofetil in Liver Transplantation Recipients Infected With Hepatitis B Virus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jeong-Ik | - |
dc.contributor.author | Song, Gi-Won | - |
dc.contributor.author | Ryu, Je Ho | - |
dc.contributor.author | Choi, Sang-Tae | - |
dc.contributor.author | Choi, Nam-Gyu | - |
dc.contributor.author | Jung, Bo-Hyun | - |
dc.contributor.author | Chu, Chong Woo | - |
dc.contributor.author | Kim, Keon-Kuk | - |
dc.contributor.author | Jung, Dong-Hwan | - |
dc.contributor.author | Ha, Tae-Yong | - |
dc.contributor.author | Moon, Deok-Bog | - |
dc.contributor.author | Yang, Kwangho | - |
dc.contributor.author | Shin, Min -Ho | - |
dc.contributor.author | Chung, Yong-Kyu | - |
dc.contributor.author | Hwang, Shin | - |
dc.contributor.author | Yoon, Young -In | - |
dc.contributor.author | Lee, Sung-Gyu | - |
dc.date.accessioned | 2023-06-11T02:41:38Z | - |
dc.date.available | 2023-06-11T02:41:38Z | - |
dc.date.created | 2023-05-30 | - |
dc.date.issued | 2023-03 | - |
dc.identifier.issn | 0041-1345 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/88061 | - |
dc.description.abstract | Background. Mycophenolate mofetil exhibits pharmacologic mechanisms different from cal-cineurin inhibitors. Therefore, the dose of calcineurin inhibitors can be reduced along with side effects for effective immunosuppression. We aimed to evaluate the efficacy and safety of tacrolimus and corticosteroid in combination with or without mycophenolate mofetil in living donor liver transplantation (LDLT) recipients infected with hepatitis B virus (HBV).Methods. A randomized, open-label, comparative, multicenter, phase IV study was conducted with 119 patients from January 2014 to September 2017. In the full analysis set population, 58 and 59 patients were included in the study group (triple-drug regimen: TacroBell + My-rept + corticosteroid) and the control group (dual-drug regimen: TacroBell + corticosteroid), respectively. In the per protocol set population, 49 and 42 patients were included in the study and control groups, respectively.Results. In the full analysis set population, the incidence of biopsy-proven acute cellular rejec-tion (rejection activity index score >= 4) was 3.4% in the study group; however, this finding was not observed in the control group (P = .468). Hepatitis B virus recurrence was observed in one patient in the control group. No cases of biopsy-proven acute cellular rejection and HBV recur-rence were observed in the per protocol set population. The incidences of serious adverse events were 25.9% and 18.0% in the study and control groups, respectively; however, the difference between the groups was not statistically significant (P = .376).Conclusion. Although the study involved a small number of patients, the triple-drug regimen can be considered safe and effective for immunosuppression after living donor liver transplanta-tion in patients infected with HBV. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.relation.isPartOf | TRANSPLANTATION PROCEEDINGS | - |
dc.title | A Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Tacrolimus and Corticosteroids in Combination With or Without Mycophenolate Mofetil in Liver Transplantation Recipients Infected With Hepatitis B Virus | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000987908000001 | - |
dc.identifier.doi | 10.1016/j.transproceed.2023.01.013 | - |
dc.identifier.bibliographicCitation | TRANSPLANTATION PROCEEDINGS, v.55, no.2, pp.387 - 395 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85148742526 | - |
dc.citation.endPage | 395 | - |
dc.citation.startPage | 387 | - |
dc.citation.title | TRANSPLANTATION PROCEEDINGS | - |
dc.citation.volume | 55 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Choi, Sang-Tae | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | REJECTION | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.